A longitudinal study of neurocognitive function in individuals at-risk for psychosis

Schizophrenia Research

Volumn 88, Issue 1-3, 2006, Pages 26-35

  Keefe, Richard S E ^a   Perkins, Diana O ^b   Gu, Hongbin ^b   Zipursky, Robert B ^c   Christensen, Bruce K ^c   Lieberman, Jeffery A ^d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d Columbia University School of Medicine ^*  (United States)

Author keywords

Development; First episode; Neurocognition; Prodrome; Psychosis; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; ALERTNESS; ARTICLE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; VERBAL MEMORY; WECHSLER INTELLIGENCE SCALE; WORKING MEMORY;

ADOLESCENT; ADULT; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 33750631049     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.06.041     Document Type: Article

References (29)

1. Brewer W.J., Wood S.J., McGorry P.D., Francey S.M., Phillips L.J., Yung A.R., et al. Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am. J. Psychiatry 160 10 (2003) 1790-1794
2. Brewer W.J., Francey S.M., Wood S.J., Jackson H.J., Pantelis C., Phillips L.J., et al. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am. J. Psychiatry 162 1 (2005) 71-78
3. Cannon M., Jones P., Huttunen M.O., Tanskanen A., Huttunen T., Rabe-Hesketh S., et al. School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study. Arch. Gen. Psychiatry 56 5 (1999) 457-463
4. Cannon M., Caspi A., Moffitt T.E., Harrington H., Taylor A., Murray R.M., et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch. Gen. Psychiatry 59 5 (2002) 449-456
5. Cornblatt B.A., and Keilp J.G. Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr. Bull. 20 1 (1994) 31-46
6. Cornblatt B., Obuchowski M., Roberts S., Pollack S., and Erlenmeyer-Kimling L. Cognitive and behavioral precursors of schizophrenia. Dev. Psychopathol. 11 3 (1999) 487-508
7. Cosway R., Byrne M., Clafferty R., Hodges A., Grant E., Abukmeil S.S., et al. Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol. Med. 30 5 (2000) 1111-1121
8. Fuller R., Nopoulos P., Arndt S., O'Leary D., Ho B.C., and Andreasen N.C. Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am. J. Psychiatry 159 7 (2002) 1183-1189
9. Hambrecht M., Lammertink M., Klosterkotter J., Matuschek E., and Pukrop R. Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic. Br. J. Psychiatry 43 (2002) s30-s37 (Suppl.)
10. Hawkins K.A., Addington J., Keefe R.S., Christensen B., Perkins D.O., Zipursky R., et al. Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophr. Res. 67 2-3 (2004) 115-122
11. Heaton R.K., Gladsjo J.A., Palmer B.W., Kuck J., Marcotte T.D., and Jeste D.V. Stability and course of neuropsychological deficits in schizophrenia. Arch. Gen. Psychiatry 58 1 (2001) 24-32
12. Insel T.R. Cure therapeutics and strategic prevention: raising the bar for mental health research. Mol. Psychiatry 11 1 (2006) 11-17
13. Isohanni I., Jarvelin M.R., Nieminen P., Jones P., Rantakallio P., Jokelainen J., et al. School performance as a predictor of psychiatric hospitalization in adult life. A 28-year follow-up in the Northern Finland 1966 Birth Cohort. Psychol. Med. 28 4 (1998) 967-974
14. Jones P., Rodgers B., Murray R., and Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344 8934 (1994) 1398-1402
15. Keefe R.S.E., Seidman L.J., Christensen B.K., Hamer R.M., Sharma T., Sitskoorn M.M., et al. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am. J. Psychiatry 161 6 (2004) 985-995
16. Keefe R.S.E., Eesley C.E., and Poe M.P. Defining a cognitive function decrement in schizophrenia. Biol. Psychiatry 57 6 (2005) 688-691
17. Keefe R.S.E., Seidman L.J., Christensen B.K., Hamer R.M., Sharma T., Sitskoorn M.M., et al. Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis. Biol. Psychiatry 59 2 (2006) 97-105
18. Klosterkotter J., Hellmich M., Steinmeyer E.M., and Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch. Gen. Psychiatry 58 2 (2001) 158-164
19. Lieberman J.A., Tollefson G., Tohen M., Green A.I., Gur R.E., Kahn R., et al. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am. J. Psychiatry 160 8 (2003) 1396-4404
20. Miller T.J., McGlashan T.H., Rosen J.L., Cadenhead K., Cannon T., Ventura J., et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr. Bull. 29 4 (2003) 703-715
21. Morey R.A., Inan S., Mitchell T.V., Perkins D.O., Lieberman J.A., and Belger A. Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Arch. Gen. Psychiatry 62 3 (2005) 254-262
22. Niemi L.T., Suvisaari J.M., Tuulio-Henriksson A., and Lonnqvist J.K. Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophr. Res. 60 2-3 (2003) 239-258
23. Nuechterlein K.H., and Dawson M.E. Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr. Bull. 10 2 (1984) 160-203
24. Phillips L.J., Yung A.R., Yuen H.P., Pantelis C., and McGorry P.D. Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia. Am. J. Med. Genet. 114 8 (2002) 929-937
25. Reichenberg A., Weiser M., Rapp M.A., Rabinowitz J., Caspi A., Schmeidler J., et al. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch. Gen. Psychiatry 62 12 (2005) 1297-130
26. Thompson P.M., Vidal C., Giedd J.N., Gochman P., Blumenthal J., Nicolson R., et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 20 (2001) 11650-11655
27. Woods S.W., Breier A., Zipursky R.B., Perkins D.O., Addington J., Miller T.J., et al. Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol. Psychiatry 54 4 (2003) 453-464
28. Yung A.r., and McGorry P.D. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust. N. Z. J. Psychiatry 30 5 (1996) 587-599
29. Zammit S., Allebeck P., David A.S., Dalman C., Hemmingsson T., Lundberg I., et al. A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other non-affective psychoses. Arch. Gen. Psychiatry 61 4 (2004) 354-360